Shanghai Model Organisms Center, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 28, 2022 at 03:06 pm EDT
Share
Shanghai Model Organisms Center, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 72.71 million compared to CNY 54.31 million a year ago. Revenue was CNY 72.71 million compared to CNY 54.31 million a year ago. Net income was CNY 13.92 million compared to CNY 11.83 million a year ago. Basic earnings per share from continuing operations was CNY 0.18 compared to CNY 0.2 a year ago. Diluted earnings per share from continuing operations was CNY 0.18 compared to CNY 0.18 a year ago.
Shanghai Model Organisms Center Inc is a China-based company mainly engaged in gene modified animal models and related technical services. The Company's businesses include genetically modified animal model, model breeding, feeding service, efficacy evaluation and phenotypic analysis, other model biotechnology services, model purchase and sales business and other businesses. The genetically modified animal model products are divided into customized models and standardized models, mainly including genetically modified mouse models, genetically modified rat models, genetically modified nematode models and genetically modified zebrafish models. The model breeding business refers to the use of genetically modified animal models developed and produced by the issuer or existing genetically modified animal models provided by customers through natural breeding or assisted reproductive breeding.